MARASCA, Roberto
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 19.811
EU - Europa 8.418
AS - Asia 2.814
SA - Sud America 64
OC - Oceania 21
Continente sconosciuto - Info sul continente non disponibili 18
AF - Africa 8
Totale 31.154
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 19.739
GB - Regno Unito 3.723
IT - Italia 1.397
SE - Svezia 1.064
CN - Cina 1.063
DE - Germania 694
HK - Hong Kong 589
SG - Singapore 498
UA - Ucraina 469
TR - Turchia 372
FI - Finlandia 342
BG - Bulgaria 205
FR - Francia 151
ID - Indonesia 76
RU - Federazione Russa 65
IN - India 63
VN - Vietnam 59
IE - Irlanda 53
CA - Canada 52
CZ - Repubblica Ceca 49
BE - Belgio 46
BR - Brasile 36
NL - Olanda 35
MY - Malesia 25
LT - Lituania 24
AU - Australia 20
IR - Iran 20
BZ - Belize 19
ES - Italia 18
EU - Europa 15
JP - Giappone 15
CL - Cile 14
RO - Romania 14
PL - Polonia 9
SI - Slovenia 9
PK - Pakistan 8
SK - Slovacchia (Repubblica Slovacca) 7
GR - Grecia 6
AR - Argentina 5
AT - Austria 5
CH - Svizzera 5
CO - Colombia 5
DK - Danimarca 5
KR - Corea 5
MK - Macedonia 5
LK - Sri Lanka 4
PH - Filippine 4
PT - Portogallo 4
PE - Perù 3
TW - Taiwan 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AE - Emirati Arabi Uniti 2
DZ - Algeria 2
EG - Egitto 2
HR - Croazia 2
HU - Ungheria 2
IQ - Iraq 2
LV - Lettonia 2
MD - Moldavia 2
RS - Serbia 2
TN - Tunisia 2
A1 - Anonimo 1
AM - Armenia 1
BD - Bangladesh 1
BO - Bolivia 1
BY - Bielorussia 1
EE - Estonia 1
IL - Israele 1
KH - Cambogia 1
KW - Kuwait 1
LU - Lussemburgo 1
MA - Marocco 1
MX - Messico 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
SY - Repubblica araba siriana 1
ZA - Sudafrica 1
Totale 31.154
Salva come PNG Salva come JPEG
Città #
Fairfield 3.247
Southend 3.187
Woodbridge 1.877
Ashburn 1.672
Houston 1.473
Chandler 1.447
Seattle 1.241
Ann Arbor 1.118
Wilmington 1.043
Cambridge 1.016
Jacksonville 970
Dearborn 837
Nyköping 746
Hong Kong 578
Modena 389
Singapore 318
Beijing 312
San Diego 300
Princeton 247
New York 232
Izmir 227
Sofia 203
Eugene 189
Helsinki 172
London 119
Fremont 110
Bremen 90
Milan 89
Redwood City 79
Jakarta 71
Des Moines 61
Boardman 60
Bologna 59
Rome 58
Dong Ket 57
San Jose 52
Shanghai 52
Dublin 49
Falls Church 49
Brussels 45
Hefei 43
Norwalk 43
Munich 34
Kunming 33
Brno 32
Chicago 31
Kilburn 31
Dallas 30
Nanjing 30
Toronto 30
Guangzhou 25
Philadelphia 25
Phoenix 25
Albuquerque 24
Frankfurt am Main 24
San Mateo 24
Las Vegas 21
Parma 21
Belize City 19
Chiswick 19
Leawood 19
Reggio Emilia 18
Verona 18
Jinan 16
Hounslow 15
Perugia 14
Washington 14
Ottawa 13
Rimini 13
Saint Petersburg 13
Caltanissetta 12
Paris 12
San Francisco 12
Segrate 12
Auburn Hills 11
Saint Louis 11
Wuhan 11
Florence 10
Fuzhou 10
Los Angeles 10
Palermo 10
Prescot 10
Romainville 10
Tulare 10
Acton 9
Amsterdam 9
Indiana 9
Ravenna 9
San Giuliano Milanese 9
Zhengzhou 9
Bangalore 8
Castelnuovo Rangone 8
Columbus 8
Dongguan 8
Islington 8
Madrid 8
Ardabil 7
Atlanta 7
Bari 7
Grafing 7
Totale 25.139
Salva come PNG Salva come JPEG
Nome #
Lenalidomide in Pretreated Mantle Cell Lymphoma Patients: An Italian Observational Multicenter Retrospective Study in Daily Clinical Practice (the Lenamant Study) 455
Monocytic population in chronic lymphocytic leukemia shows altered composition and deregulation of genes involved in phagocytosis and inflammation 407
BCR-ABL-specific T-cell therapy in Ph+ ALL patients on tyrosine-kinase inhibitors 281
Development of hypogammaglobulinemia in patients treated with imatinib for chronic myeloid leukemia or gastrointestinal stromal tumor 281
SVILUPPO DI IPOGAMMAGLOBULINEMIA IN PAZIENTI TRATTATI CON IMATINIB PER LEUCEMIA MIELOIDE CRONICA O TUMORI STROMALI GASTROINTESTINALI 278
Characterization of Specific Immune Responses to Different Aspergillus Antigens during the Course of Invasive Aspergillosis in Hematologic Patients 259
Idelalisib impairs T-cell-mediated immunity in chronic lymphocytic leukemia 243
NPM1 mutations may reveal acute myeloid leukemia in cases otherwise morphologically diagnosed as myelodysplastic syndromes or myelodysplastic/myeloproliferative neoplasms 241
Epidemiology and clinical outcome of lower respiratory tract infections by respiratory syncytial virus or parainfluenza virus type 3 in adults receiving treatment for either acute leukemia or severe aplastic anemia: a retrospective single center study 238
Pathogenetic mechanisms of hepatitis C virus-induced B-cell lymphomagenesis. 238
Detection of Fusarium-specific T cells in hematologic patients with invasive fusariosis 235
Ibrutinib modifies the function of monocyte/macrophage population in chronic lymphocytic leukemia 225
A case of JAK2 V617F-positive myelodysplastic/myeloproliferative neoplasm with unusual morphology, resembling acute promyelocytic leukemia-like disorder with a chronic course. 224
The bone marrow represents an enrichment site of specific T lymphocytes against filamentous fungi 214
Endothelin-1 promotes survival and chemoresistance in chronic lymphocytic leukemia B cells through eta receptor 212
Effectiveness of originator (Neupogen) and biosimilar (Zarzio) filgrastim in autologous peripheral blood stem cell mobilization in adults with acute myeloid leukemia: a single-center retrospective study 208
Increased SHISA3 expression characterizes chronic lymphocytic leukemia patients sensitive to lenalidomide 208
Atraumatic splenic rupture in patients with myelodysplastic syndromes: Report of a case occurred during treatment with 5-azacitidine and review of the literature. 206
Lenalidomide interferes with tumor-promoting properties of nurse-like cells in chronic lymphocytic leukemia 203
Mucorales-specific T cells in patients with hematologic malignancies 201
Chronic eosinophilic leukaemia with ETV6-NTRK3 fusion transcript in an elderly patient affected with pancreatic carcinoma 199
May the indirect effects of CIHHV-6 in transplant patients be exerted through the reactivation of the viral replicative machinery? 197
An unusual case of B-ALL occurring in a patient with acute promyelocytic leukemia in remission after two hematopoietic SCTs: whose are the leukemic cells? 196
Antineoplastic effects of liposomal siRNA treatment targeting BLIMP1/PRDM1 in primary effusion lymphoma 195
BCR-ABL-specific cytotoxic T cells in the bone marrow of patients with Ph(+) acute lymphoblastic leukemia during second-generation tyrosine-kinase inhibitor therapy. 194
Characterization and dynamics of specific T cells against nucleophosmin-1 (NPM1)-mutated peptides in patients with NPM1-mutated acute myeloid leukemia 193
NOTCH1 mutations in +12 chronic lymphocytic leukemia (CLL) confer an unfavorable prognosis, induce a distinctive transcriptional profiling and refine the intermediate prognosis of +12 CLL 191
The importance of cytogenetic and molecular analyses in eosinophilia-associated myeloproliferative neoplasms: an unusual case with normal karyotype and TNIP1- PDGFRB rearrangement and overview of PDGFRB partner genes 189
Targeting neoplastic B cells and harnessing microenvironment: the “double face” of ibrutinib and idelalisib 189
The oncogenic 30 and 69 bp deletion variants of the EBV LMP-1 gene are common in HIV-negative lymphoproliferations, both malignant and benign 189
Circulating functional T cells specific to human herpes virus 6 (HHV6) antigens in individuals with chromosomally integrated HHV6 188
Physical contact with endothelial cells through β1- and β2- integrins rescues chronic lymphocytic leukemia from spontaneous and drug-induced apoptosis and induces a peculiar gene expression profile on leukemic cells. 188
Increased expression of angiopoietin-2 characterizes early B-cell chronic lymphocytic leukemia with poor prognosis 186
Gene expression profiling of acute promyelocytic leukaemia identifies two subtypes mainly associated with Flt3 mutational status 186
The expression of endothelin-1 in chronic lymphocytic leukemia is controlled by epigenetic mechanisms and extracellular stimuli. 186
ANGPT2 promoter methylation is strongly associated with gene expression and prognosis in chronic lymphocytic leukemia 186
Managing chronic myeloid leukemia for treatment-free remission: a proposal from the GIMEMA CML WP 185
Targeted integration of human herpesvirus 6 in the p arm of chromosome 17 of human peripheral blood mononuclear cells in vivo 184
The genetics of nodal marginal zone lymphoma 184
Multiple myeloma shows no intra-disease clustering of immunoglobulin heavy chain genes 184
Immunoglobulin gene mutations and frequent use of VH1-69 and VH4-34 segments in hepatitis C virus-positive and hepatitis C virus-negative nodal marginal zone B-cell lymphoma 182
Ruxolitinib for pulmonary extramedullary hematopoiesis in myelofibrosis 181
The Krüppel-like factor 2 transcription factor gene is recurrently mutated in splenic marginal zone lymphoma 181
13q14 deletion size and number of deleted cells both influence prognosis in chronic lymphocytic leukemia 180
B-cell receptor, clinical course and prognosis in chronic lymphocytic leukaemia: the growing saga of the IGHV3 subgroup gene usage. 179
Stereotyped patterns of B-cell receptor in splenic marginal zone lymphoma. 179
Chronic and recurrent benign lymphadenopathy without constitutional symptoms associated with human herpesvirus-6B reactivation 179
Randomized phase 2 study: Elotuzumab plus bortezomib/dexamethasone vs bortezomib/dexamethasone for relapsed/refractory MM 179
Alteration of BIRC3 and multiple other NF-κB pathway genes in splenic marginal zone lymphoma 174
Macitentan, a double antagonist of endothelin receptors, efficiently impairs migration and microenvironmental survival signals in chronic lymphocytic leukemia 174
Long-term salvage therapy with cyclosporin A in refractory idiopathic thrombocytopenic purpura. 173
Aspirin, Warfarin, or Enoxaparin Thromboprophylaxis in Patients With Multiple Myeloma Treated With Thalidomide: A Phase III, Open-Label, Randomized Trial. 173
Efficacy of bendamustine and rituximab as first salvage treatment in chronic lymphocytic leukemia and indirect comparison with ibrutinib: A GIMEMA, ERIC and UK CLL FORUM study 173
Age and organ damage correlate with poor survival in myeloma patients: meta-analysis of 1435 individual patient data from 4 randomized trials 173
Intrinsic and extrinsic factors influencing the clinical course of B-cell chronic lymphocytic leukemia: prognostic markers with pathogenetic relevance 173
Angiopoietin-2 acts as a survival factor for chronic lymphocytic leukemia B cells throughout Tie-2 receptor engagement 171
Endothelium-mediated survival of leukemic cells and angiogenesis-related factors are affected by lenalidomide treatment in chronic lymphocytic leukemia 171
The PI3-kinase delta inhibitor idelalisib (GS-1101) targets integrin-mediated adhesion of chronic lymphocytic leukemia (CLL) cell to endothelial and marrow stromal cells 170
Increased angiogenesis induced by chronic lymphocytic leukemia B cells is mediated by leukemia-derived Ang2 and VEGF. 170
Chronic myeloid leukemia with thrombocythemic onset may be associated with different BCR/ABL variant transcripts 169
Sensitive detection of circulating breast cancer cells by reverse-transcriptase polymerase chain reaction of maspin gene 169
Human Herpes virus-6 in human lymphomas: identification of specific sequences in Hodgkin's lymphomas by polymerase chain reaction 169
Angiopoietin-2 expression in B-cell chronic lymphocytic leukemia: association with clinical outcome and immunoglobulin heavy-chain mutational status 169
Molecular prediction of durable remission after first-line fludarabinecyclophosphamide-rituximab in chronic lymphocytic leukemia 168
Angiopoietin-2 plasma dosage predicts time to first treatment and overall survival in chronic lymphocytic leukemia. 168
Peripheral lymphadenopathy: role of excisional biopsy in differential diagnosis based on a five-year experience. 167
Immunoglobulin mutational status detected through single-round amplification of partial VH region, represents a good prognostic marker for the clinical outcome in chronic lymphocytic leukemia 167
A variant of the LRP4 gene affects the risk of chronic lymphocytic leukaemia transformation to Richter syndrome 167
Mucorles-specific T cells emerge in the course of invasive mucormucosis and may be used as a surrogate diagnostic marker in high-risk patients 167
Lack of confirmation of an association between HTLV-I infection and myelodysplastic syndrome 166
All-trans retinoic acid (ATRA) in non-promyelocytic acute myeloid leukemia (AML): results of combination of ATRA with low-dose Ara-C in three elderly patients with NPM1-mutated AML unfit for intensive chemotherapy and review of the literature 166
Long-term molecular remission with persistence of BCR-ABL1-specific cytotoxic T cells following imatinib withdrawal in an elderly patient with Philadelphia-positive ALL 166
Severe anemia in a patient with multiple sclerosis treated with natalizumab 165
Integrated mutational and cytogenetic analysis identifies new prognostic subgroups in chronic lymphocytic leukemia 165
Acute myeloid leukemia in patients living with HIV infection: Several questions, fewer answers 165
Differences among young adults, adults and elderly chronic myeloid leukemia patients 163
Chromosome 14q32 translocations involving the immunoglobulin heavy chain locus in chronic lymphocytic leukaemia identify a disease subset with poor prognosis. 161
Practical management of ibrutinib in the real life: Focus on atrial fibrillation and bleeding 160
Association between molecular lesions and specific B-cell receptor subsets in chronic lymphocytic leukemia 160
BK virus infection and neurologic dysfunctions in a patient with lymphoma treated with chemotherapy and rituximab 159
Missense mutations in the PML/RAR alpha ligand binding domain in ATRA-resistant As2O3 sensitive relapsed acute promyelocytic leukemia 157
Human herpesvirus-6 genome in acute lymphoblastic leukemia: Evidence against an etiologic relationship 157
Bone marrow failure associated with human herpesvirus 8 infection after transplantation 156
IGHV gene mutational status and 17p deletion are independent molecular predictors in a comprehensive clinical-biological prognostic model for overall survival prediction in chronic lymphocytic leukemia. 156
BCR-ABL rearrangement is not detectable in essential thrombocythemia. 156
Chronic/relapsing lymphadenopathy associated with HHV-6B infection: a new benign clinico-pathologic entity occurring in immunocompetent individuals 156
Bortezomib-melphalan-prednisone-thalidomide followed by maintenance with bortezomib-thalidomide compared with bortezomib-melphalan-prednisone for initial treatment of multiple myeloma: updated follow-up and improved survival 155
Lenalidomide in chronic lymphocytic leukemia: The present and future in the era of tyrosine kinase inhibitors 153
Two main genetic pathways lead to the transformation of chronic lymphocytic leukemia to Richter syndrome 152
Vorinostat and bortezomib significantly inhibit WT1 gene expression in MO7-e and P39 cell lines 151
Analysis of the chronic lymphocytic leukemia coding genome: role of NOTCH1 mutational activation 151
HUMAN HERPESVIRUS-6 - A SURVEY OF PRESENCE AND DISTRIBUTION OF GENOMIC SEQUENCES IN NORMAL BRAIN AND NEUROGLIAL TUMORS 151
HHV-8-associated primary cerebral B-cell lymphoma in HIV-negative patient after long-term steroids 150
Expression of cell-homologous genes of human herpesvirus-8 in human immunodeficiency virus-negative lymphoproliferative diseases 150
Safety and efficacy of bortezomib-melphalan-prednisone-thalidomide followed by bortezomib-thalidomide maintenance (VMPT-VT) versus bortezomib-melphalan-prednisone (VMP) in untreated multiple myeloma patients with renal impairment 150
Tumor evolutionary directed graphs and the history of chronic lymphocytic leukemia 150
The role of molecular monitoring in autotransplantation for non-Hodgkin's lymphoma 149
Polymerase chain reaction detection of human herpesvirus 8 sequences in primary central nervous system lymphomas 148
Spontaneous adrenal gland haematoma in a patient with antiphospholipid antibodies 148
Minimal/Measurable Residual Disease Monitoring in NPM1-Mutated Acute Myeloid Leukemia: A Clinical Viewpoint and Perspectives 148
Totale 18.701
Salva come PNG Salva come JPEG
Categoria #
all - tutte 145.641
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 145.641
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20206.172 0 0 0 457 718 1.020 1.495 884 655 270 362 311
2020/20215.856 413 272 453 668 850 480 367 674 244 676 397 362
2021/20224.275 197 548 517 206 99 235 259 192 398 307 698 619
2022/20234.255 503 482 325 374 579 570 81 445 488 51 190 167
2023/20242.972 104 162 172 272 562 270 349 452 54 68 188 319
2024/2025703 313 123 141 126 0 0 0 0 0 0 0 0
Totale 31.657